Jim Cramer Blog

Friday's show began with Cramer analysing two new stocks Cramer wants you to buy after the big sell off in the market on Thursday. Cramer said he likes to buy supermarket and drugstore stocks after down days because investors consider them to be safe. His picks were Avon (AVP) and Clorox (CLX). Cramer thinks that they both are doing well internationally, that they have good growth prospects, and that the CEOs of both companies have turned things around.
Tekelec (TKLC): Cramer talked about his weekly speculative pick. They make telecommunications equipment that is focused on next generation networks, giving it strong growth prospects. Cramer also likes that they just completed a stock buyback, meaning they have more cash than some of his speculative plays. Cramer thinks that the stock could go to $16, and that it might be a buyout target for a larger telecommunications company.
After the lightning round, Cramer discussed his Game Plan for next week. He thinks that Citigroup (C) CEO Chuck Prince will either leave the company this weekend, or not at all. If he is still around after Monday, Cramer wants you to move on.
Cramer then talked to Diana Shipping (DSX) CEO Simeon Palios about dry bulk shipping rates, and he left Cramer less bullish about the dry bulk shippers than he had been.
Cramer brought up his earnings plays for this week. Cisco (CSCO) reports on Wednesday, and Cramer thinks you should buy the stock before then. Hologic (HOLX) reports on Tuesday, and Cramer thinks you should also buy some of their stock before they report. He also said that Foster Wheeler (FWLT) and Allergan (AGN) have gone down in the past after earnings, which he thinks is a chance to get these stocks on sale. Cramer also said that he wants you to sell CBS (CBS) and buy ConEd (ED) because it has higher growth and a larger dividend.
Cramer has the CEO of GFI Group (GFIG) on the phone, and they talked about the company's position in the brokerage market, and Cramer said that he is bullish on the stock.

Labels: AVP, CBS, CLX, CNBC, CSCO, DSX, HOLX, Jim Cramer, Mad Money, TKLC

Repros Therapeutics Inc. (NasdaqGM:RPRX - News) announced the pricing of its public offering of 2.61 million shares at $13.75 each. The underwriters have a 30-day option to purchase up to an additional 390,000 shares of common stock to cover over-allotments, if any, the company said.
Saifun Semiconductor (NasdaqGS:SFUN - News) shares slumped after the company reported fourth-quarter earnings of $6.3 million, or 20 cents per share, down from a year-ago profit of $8.6 million, or 15 cents a share. Revenue at the Israeli chip company declined to $14 million in the quarter from $16.7 million a year ago.
SanDisk (NasdaqGS:SNDK - News) said it swung to a fourth-quarter loss from a year ago, hurt by acquisition-related charges, as sales surged amid increased demand for its NAND flash-memory storage chips used in consumer electronics.
Sepracor Inc. (NasdaqGS:SEPR - News) said fourth-quarter earnings rose to $99.1 million, or 85 cents a share, from $36.9 million, or 31 cents a share, a year earlier. The results include a 12 cents a share charge for stock-based compensation. Revenue increased to $357.2 million from last year's $311.1 million. Analysts surveyed by Thomson Financial had been expecting earnings of 62 cents a share and revenue of $341.4 million, on average.
Selective Insurance Group (NasdaqGS:SIGI - News) was initiated with a market perform rating at Wachovia Securities, citing concerns about increasing competition.
Silicon Laboratories (NasdaqGS:SLAB - News) forecast revenue of $106 million to $111 million for the fiscal first quarter, below Wall Street's current consensus estimate for revenue of $113.5 million in the March period.
Tekelec (NasdaqGM:TKLC - News) was downgraded to hold at Jefferies & Co.
Time Warner Inc. (NYSE:TWX - News) reported fourth-quarter net income of $1.75 billion, or 44 cents a share, up from $1.3 billion, or 28 cents, earned in the same period during 2005. Earnings from continuing operations improved to 43 cents a share from 28 cents, the New York-based media giant's results showed. Backing out one-time items, Time Warner said it would have earned 22 cents a share for the latest quarter. Quarterly revenue reached $12.47 billion from the prior year's $11.52 billion. Analysts were looking for earnings of 22 cents a share on revenue of $12.46 billion, according to estimates compiled by Thomson First Call. The company also said it expects to wrap up a $20 billion stock-buyback program during the first half of 2007.
Tupperware Brands Corp. (NYSE:TUP - News) reported fourth-quarter net earnings of $39.9 million, or 65 cents a share, up 28% from $31.2 million, or 51 cents a share, during the year-ago period. Earnings after adjustments were 74 cents a share.
Websense (NasdaqGS:WBSN - News) shares tumbled after the company said its fourth-quarter earnings fell 30%, due in part to the cost of starting distribution of its software through Ingram Micro Inc. in North America. The San Diego provider of employee Internet management software had fourth-quarter earnings of $7.78 million, or 17 cents a share, compared with $11.1 million, or 23 cents a share, a year earlier. Excluding stock-based compensation expense, the company earned $11.4 million, or 25 cents a share, up 3% from a year earlier. Revenue for the quarter ended Dec. 31 rose 18% to $47.3 million from $40.1 million a year ago. Analysts surveyed by Thomson Financial expected, on average, earnings of 25 cents a share on revenue of $48 million. Analyst earnings forecasts typically exclude unusual items. In addition, Websense said it expects first-quarter earnings of 9 to 11 cents a share and first-quarter non-GAAP earnings of 19 to 21 cents a share.
W Holding Co. (NYSE:WHI - News) shares fell after the company posted a profit of $17.9 million, or 5 cents a share, for the fourth quarter, down nearly 41% from last year's earnings of $30.2 million, or 12 cents a share. The holding company for Westernbank Puerto Rico attributed the latest results to increases in its current income tax provision, non-interest expenses, and its provision for loan losses.
YMI Biosciences (AMEX:YMI - News) shares plunged after the company said it's terminating a phase III trial of testmilifene, a proposed advanced breast cancer treatment. The company said the move follows a recommendation from the independent Data Safety Monitoring Board that the trial be stopped because interim analysis indicates "it is very unlikely significant differences in overall survival will be shown" between treatment arms as the data mature. A.G. Edwards downgraded the company to hold from buy following the news.
Published By MarketWatch

Labels: RPRX, SEPR, SFUN, SIGI, SLAB, SNDK, TKLC, TUP, TWX, WBSN, WHI, YMI